Hon Hai Precision Industry Co (鴻海精密), which assembles Apple Inc’s iPads and iPhones, yesterday reported that its consolidated revenue last month was the highest in 11 months and had increased 12.86 percent from a month earlier.
Revenue was NT$621.71 billion (US$22.43 billion), up from NT$550.89 billion in October, the company said in a statement.
Last month’s results were in line with market expectations, as the company was gearing up to assemble new iPhone models and other electronics for the year-end shopping season.
Photo: Fang Wei-jie, Taipei Times
Hon Hai is a leading electronics manufacturing service company that primarily manufactures computer hardware, handsets and networking products for major global brands. It has four main business divisions: consumer and intelligent electronics, cloud and networking technology, computing products and components.
Compared with October, Hon Hai said it benefited from robust business at its components division, followed by its consumer and intelligent electronics division, its computing products division and then its cloud and networking businesses.
On an annual basis, revenue was down 8.76 percent, Hon Hai said, adding that its components division reported the highest sales growth, ahead of the cloud and networking, computing products and consumer and intelligent electronics divisions.
The company’s revenue for last month was the second highest on record for November, Hon Hai data showed.
For the first 11 months of the year, revenue totaled NT$5.28 trillion, up 13.67 percent from NT$4.64 trillion in the same period last year and the highest on record for the period.
Last week, Bloomberg News reported that Apple had told suppliers that demand for the iPhone 13 lineup had slowed, suggesting that interest among consumers for new iPhones is declining, which could affect the US company’s suppliers in Asia.
For Hon Hai, uncertainties from tight component supply and the COVID-19 pandemic to competition from Chinese peers would remain in the near term, analysts said.
While the company has been developing electric vehicle, robot and digital healthcare businesses as potential revenue drivers, their contributions would initially be limited because of low order visibility and Hon Hai’s huge sales scale, analysts said.
This time was supposed to be different. The memorychip sector, famous for its boom-and-bust cycles, had changed its ways. A combination of more disciplined management and new markets for its products — including 5G technology and cloud services — would ensure that companies delivered more predictable earnings. Yet, less than a year after memory companies made such pronouncements, the US$160 billion industry is suffering one of its worst routs ever. There is a glut of the chips sitting in warehouses, customers are cutting orders and product prices have plunged. “The chip industry thought that suppliers were going to have better control,” said
Enimmune Corp (安特羅生技) has obtained marketing approval from the Food and Drug Administration (FDA) for its EnVAX-A71 vaccine for enterovirus 71 (EV-71), becoming the nation’s first enterovirus vaccine completely made in Taiwan, it said yesterday. After spending 13 years and NT$1.5 billion (US$49.77 million) on the research and development of the vaccine, Enimmune plans to start manufacturing and marketing it by the end of March, the company said in a statement, without disclosing customer order figures. “It is possible that the vaccine would not be included in a national vaccination program initially, and consumers would need to pay for it themselves,” parent
Vaccine skeptics blocking transfusions for life-saving surgeries, Facebook groups inciting violence against doctors and a global search for unvaccinated donors — COVID-19 misinformation has bred a so-called “pure blood” movement. The movement spins anti-vaccine narratives focused on unfounded claims that receiving blood from people inoculated against COVID-19 “contaminates” the body. Some have advocated for blood banks that draw from “pure” unvaccinated people, while medics in North America say they have fielded requests from people demanding transfusions from donors who have not received a vaccine. In closed social media groups, vaccine skeptics — who brand themselves as “pure bloods” — promote violence against doctors
Asteroid mining start-up AstroForge Inc is planning to launch its first two missions to space this year as it seeks to extract and refine metals from deep space. The first launch, scheduled for April, is to test AstroForge’s technique for refining platinum from a sample of asteroid-like material. The second, planned for October, would scout for an asteroid near Earth to mine. The missions are part of AstroForge’s goal of refining platinum-group metals from asteroids, with the aim of bringing down the cost of mining these metals. It also hopes to reduce the massive amount of carbon emissions that stem from mining